Fulgent Genetics, Inc. (FLGT) compared with its closest peers (BLLN, CSTL, CDNA, VCYT, GRAL). Peer set by Healthcare Services; 10 comparable companies. First-party data.
BillionToOne, Castle Biosciences, CareDx, Veracyte, GRAIL, Caris Life Sciences, Lumexa Imaging Holdings, Inc. Common Stock, Guardant Health, Biodesix and Personalis share Fulgent Genetics's sub-industry, medical laboratories.
| Company | Market Cap | P/E |
|---|---|---|
| BillionToOne, Inc. (BLLN) | $5.45B | 172.9 |
| Castle Biosciences, Inc. (CSTL) | $1.07B | -46.9 |
| CareDx, Inc (CDNA) | $2.63B | 22.3 |
| Veracyte, Inc. (VCYT) | $3.52B | 30.7 |
| GRAIL, Inc. (GRAL) | $3.54B | -7.7 |
| Caris Life Sciences, Inc. (CAI) | $7.91B | -8.4 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.13B | 656.4 |
| Guardant Health, Inc. (GH) | $22.13B | -30.8 |
| Biodesix, Inc. (BDSX) | $294.06M | -1.5 |
| Personalis, Inc. (PSNL) | $1.84B | -8.8 |
| Sector P/E (Healthcare) | 21.9 |
| Industry P/E (Healthcare Services) | 25.4 |
FLGT overview · FLGT earnings · FLGT financials · FLGT KPIs · FLGT documents · FLGT ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.